Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system.
Brocke S, Hausmann S, Steinman L, Wucherpfennig KW. Brocke S, et al. Semin Immunol. 1998 Feb;10(1):57-67. doi: 10.1006/smim.1997.0105. Semin Immunol. 1998. PMID: 9529656 Review.
The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit.
Brocke S, Dayan M, Rothbard J, Fuchs S, Mozes E. Brocke S, et al. Immunology. 1990 Apr;69(4):495-500. Immunology. 1990. PMID: 1692300 Free PMC article.
TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.
Preller V, Gerber A, Wrenger S, Togni M, Marguet D, Tadje J, Lendeckel U, Röcken C, Faust J, Neubert K, Schraven B, Martin R, Ansorge S, Brocke S, Reinhold D. Preller V, et al. Among authors: brocke s. J Immunol. 2007 Apr 1;178(7):4632-40. doi: 10.4049/jimmunol.178.7.4632. J Immunol. 2007. PMID: 17372022
Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L, Born I, Faust J, Neubert K, Martin R, Ansorge S, Brocke S. Steinbrecher A, et al. Among authors: brocke s. J Immunol. 2001 Feb 1;166(3):2041-8. doi: 10.4049/jimmunol.166.3.2041. J Immunol. 2001. PMID: 11160254
Superantigens in demyelinating disease.
Brocke S, Piercy C, Steinman L. Brocke S, et al. Springer Semin Immunopathol. 1996;18(1):51-6. doi: 10.1007/BF00792608. Springer Semin Immunopathol. 1996. PMID: 8984679 Review. No abstract available.
Isolation and Characterization of Autoreactive T Cells in Experimental Autoimmune Encephalomyelitis of the Mouse.
Brocke S, Quigley L, McFarland HF, Steinman L. Brocke S, et al. Methods. 1996 Jun;9(3):458-62. doi: 10.1006/meth.1996.0053. Methods. 1996. PMID: 8812701
Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation.
Gijbels K, Brocke S, Abrams JS, Steinman L. Gijbels K, et al. Among authors: brocke s. Mol Med. 1995 Nov;1(7):795-805. Mol Med. 1995. PMID: 8612202 Free PMC article.
Infection and multiple sclerosis: a possible role for superantigens?
Brocke S, Veromaa T, Weissman IL, Gijbels K, Steinman L. Brocke S, et al. Trends Microbiol. 1994 Jul;2(7):250-4. doi: 10.1016/0966-842x(94)90630-0. Trends Microbiol. 1994. PMID: 8081652 Review.
In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis.
Ufret-Vincenty RL, Quigley L, Tresser N, Pak SH, Gado A, Hausmann S, Wucherpfennig KW, Brocke S. Ufret-Vincenty RL, et al. Among authors: brocke s. J Exp Med. 1998 Nov 2;188(9):1725-38. doi: 10.1084/jem.188.9.1725. J Exp Med. 1998. PMID: 9802984 Free PMC article.
Chronic relapsing experimental autoimmune encephalomyelitis: effects of insulin-like growth factor-I treatment on clinical deficits, lesion severity, glial responses, and blood brain barrier defects.
Li W, Quigley L, Yao DL, Hudson LD, Brenner M, Zhang BJ, Brocke S, McFarland HF, Webster HD. Li W, et al. Among authors: brocke s. J Neuropathol Exp Neurol. 1998 May;57(5):426-38. doi: 10.1097/00005072-199805000-00006. J Neuropathol Exp Neurol. 1998. PMID: 9596413
85 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page